Rimonabant is an anorectic antiobesity drug that was first approved in Europe in 2006 but was approved the sale of rimonabant in the then-25-member European Union as a prescription drug for use in conjunction with diet and exercise for . FDA Briefing Document NDA 21-888 Zimulti (rimonabant)...